Starling Oncology Institute Inc (STLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,739 | 49,669 | 47,402 | 36,424 | 36,055 |
| Marketable Securities | N/A | N/A | 0 | 9,939 | 29,777 |
| Receivables | 49,666 | 48,681 | 54,860 | 54,367 | 59,128 |
| Inventories | 12,308 | 10,039 | 10,106 | 11,322 | 11,554 |
| TOTAL | $106,820 | $112,418 | $116,425 | $116,209 | $141,192 |
| Non-Current Assets | |||||
| PPE Net | 11,116 | 11,888 | 12,274 | 12,232 | 10,995 |
| Intangibles | 21,266 | 22,040 | 22,813 | 23,587 | 24,361 |
| Other Non-Current Assets | 24,800 | 26,371 | 27,671 | 27,574 | 27,984 |
| TOTAL | $57,182 | $60,299 | $62,758 | $63,393 | $63,340 |
| Total Assets | $164,002 | $172,717 | $179,183 | $179,602 | $204,532 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 29,291 | 24,324 | 24,572 | 15,750 | 21,015 |
| Accrued Expenses | 23,434 | 21,093 | 15,436 | 12,831 | 18,363 |
| TOTAL | $59,541 | $52,215 | $46,757 | $35,102 | $45,768 |
| Non-Current Liabilities | |||||
| Long Term Debt | 73,894 | 93,131 | 91,537 | 89,950 | 88,385 |
| Other Non-Current Liabilities | 25,466 | 23,750 | 25,375 | 25,312 | 29,051 |
| TOTAL | $99,392 | $116,913 | $116,944 | $115,294 | $117,468 |
| Total Liabilities | $158,933 | $169,128 | $163,701 | $150,396 | $163,236 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89,234 | 75,753 | 75,559 | 75,490 | 74,438 |
| Common Shares | 9 | 8 | 8 | 8 | 8 |
| Retained earnings | -230,398 | -210,813 | -197,631 | -181,518 | -166,039 |
| Other shareholders' equity | -19 | -19 | -19 | -19 | -19 |
| TOTAL | $5,069 | $3,589 | $15,482 | $29,206 | $41,296 |
| Total Liabilities And Equity | $164,002 | $172,717 | $179,183 | $179,602 | $204,532 |